Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies

Patients suffering from acute myeloid leukemias (AML) bearing FMS-like tyrosine kinase-3-internal tandem duplications (FLT3-ITD) have poor outcomes following cytarabine- and anthracyclin-based induction therapy. To a major part this is attributed to drug resistance of FLT3-ITD-positive leukemic cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasper, S, Breitenbuecher, F, Heidel, F, Hoffarth, S, Markova, B, Schuler, M, Fischer, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317524/
https://www.ncbi.nlm.nih.gov/pubmed/22829255
http://dx.doi.org/10.1038/bcj.2012.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317524/
https://www.ncbi.nlm.nih.gov/pubmed/22829255
http://dx.doi.org/10.1038/bcj.2012.5

Ejemplares similares